Running marathons with type 1 diabetes can be safe, shows small study using continuous glucose monitoring devices Written By Dr. Kamal Kant Kohli9 Nov 2026 8:00 AM ISTNew research to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28th – Oct 2nd)...
Low-fat vegan diet cuts liver fat by a third and improves insulin function in adults with type 2 diabetes, finds study Written By Dr. Kamal Kant Kohli31 Oct 2026 9:30 AM ISTAdults with type 2 diabetes who followed a low-fat vegan diet for 16 weeks, eating as much as they wanted, with no calorie counting or portion...
CGM Linked to Lower Mortality and Cardiovascular Risk in Basal Insulin-Treated Type 2 Diabetes: Study Written By Dr. Kamal Kant Kohli15 Oct 2026 8:30 PM ISTPeople with type 2 diabetes (T2D) on basal insulin, starting continuous glucose monitoring (CGM) had a 44% lower risk of dying from any cause after...
FDA Approves Once-Weekly Basal Insulin Efsitora for Type 2 Diabetes Written By Dr. Kamal Kant Kohli15 Oct 2026 12:15 PM ISTThe FDA has approved efsitora (Onswik), a once-weekly basal insulin, for adults with type 2 diabetes as an adjunct to diet and exercise. The therapy...
Newer insulin may reduce dangerous low blood sugar in youth with Type 1 diabetes in low-resource settings: Study warns Written By Dr. Kamal Kant Kohli13 Oct 2026 9:45 AM ISTA trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to the question of...
Dapagliflozin-Metformin in the Diabetes Care Continuum: When to Consider?- Dr Praveen G Written By Dr Praveen Gangadhara12 Oct 2026 10:49 AM ISTCombination Therapy-Pillars in Diabetes Care Continuum Type 2 diabetes mellitus (T2DM) represents a significant and escalating health challenge,...
GLP-1 Drugs Do Not Increase Insulin Discontinuation Compared With Other Diabetes Medications: Study Written By Medha Baranwal9 Oct 2026 11:45 AM ISTUSA: A study published in the Annals of Internal Medicine has found that glucagon-like peptide-1 (GLP-1) receptor agonists do not significantly...
Short Exercise Bursts Linked to Better Fitness and Blood Sugar Control: Study Written By Anshika Mishra8 Oct 2026 8:15 AM ISTShort bursts of exercise spread throughout the day may improve cardiorespiratory fitness and some measures of metabolic health in sedentary adults,...
New daily orforglipron pill demonstrated cardiovascular safety in its largest and longest study of type 2 diabetes (ACHIEVE-4 study) Written By Dr. Kamal Kant Kohli6 Oct 2026 11:15 AM ISTNew research presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28-Oct 2) and...
Using Dapagliflozin & Sitagliptin FDC Early in Uncontrolled T2D: A Beta Cell Preservation Approach in 2026-Dr Rajesh Deshmane Written By Dr Rajesh Deshmane22 Sept 2026 10:28 AM ISTIn type 2 diabetes (T2D), pancreatic β-cells function deteriorates progressively, accelerating after disease onset (at 1.8 - 9.5% per year) due to...
FDA Clears Beta Bionics' Mint Smartphone-Controlled Patch Pump Written By Dr. Kamal Kant Kohli18 Sept 2026 8:30 AM ISTThe FDA has cleared Beta Bionics' Mint, a smartphone-controlled insulin patch pump featuring a reusable controller and disposable pump design. The...
Medical Bulletin 31/August/2026 Written By Anshika Mishra31 Aug 2026 3:00 PM ISTHere are the top medical news for today:Type 1 Diabetes Cases Could Increase 29% Globally by 2049, Study Estimates A new global analysis projects a...
